Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,035 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genomics, Morphoproteomics, and Treatment Patterns of Patients with Alveolar Soft Part Sarcoma and Response to Multiple Experimental Therapies.
Groisberg R, Roszik J, Conley AP, Lazar AJ, Portal DE, Hong DS, Naing A, Herzog CE, Somaiah N, Zarzour MA, Patel S, Brown RE, Subbiah V. Groisberg R, et al. Among authors: brown re. Mol Cancer Ther. 2020 May;19(5):1165-1172. doi: 10.1158/1535-7163.MCT-19-0579. Epub 2020 Mar 3. Mol Cancer Ther. 2020. PMID: 32127467 Free PMC article.
Antitumor Response to Combined Antiangiogenic and Cytotoxic Chemotherapy in Recurrent Metastatic Chromophobe Renal Cell Carcinoma: Response Signatures and Proteomic Correlates.
Maiti A, Brown RE, Corn PG, Murthy R, Ganeshan DM, Tsimberidou AM, Subbiah V. Maiti A, et al. Among authors: brown re. Clin Genitourin Cancer. 2016 Apr;14(2):e187-93. doi: 10.1016/j.clgc.2015.11.004. Epub 2015 Nov 11. Clin Genitourin Cancer. 2016. PMID: 26684814 Free PMC article. No abstract available.
Morphoproteomics and biomedical analytics confirm the mTORC2/Akt pathway as a resistance signature and activated ERK and STAT3 as concomitant prosurvival/antiapoptotic pathways in metastatic renal cell carcinoma (RCC) progressing on rapalogs: pathogenesis and therapeutic options.
Brown RE, Buryanek J, Tammisetti VS, McGuire MF, Csencsits-Smith K. Brown RE, et al. Oncotarget. 2016 Jul 5;7(27):41612-41621. doi: 10.18632/oncotarget.9508. Oncotarget. 2016. PMID: 27223432 Free PMC article.
1,035 results